Levin Capital Strategies L.P. Makes New Investment in Lucid Diagnostics Inc. (NASDAQ:LUCD)
Levin Capital Strategies L.P. bought a new position in Lucid Diagnostics Inc. (NASDAQ:LUCD – Get Rating) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 36,799 shares of the company’s stock, valued at approximately $50,000. Levin Capital Strategies L.P. owned about 0.09% of Lucid […]